Biota Pharma reports FQ2 results

• Biota Pharmaceuticals (BOTA) FQ2 results: Revenues: $1.7M (-87.8%); R&D Expense: $6.3M (+31.3%); SG&A: $2.1M (-19.2%); Net Loss: ($6.5M) (-200.0%); Loss Per Share: ($0.17) (-189.5%); Quick Assets: $52M (-9.7%).
• No guidance given.